Bilateral oophorectomy before menopause affects cognitive ability: JAMA
Rochester, MN: A case-control study by Walter A. Rocca, MD, MPH, and team revealed that women who underwent bilateral oophorectomy before menopause were at increased risk of developing mild cognitive impairment (MCI). Also, such women performed poorly on cognitive tests approximately 30 years later compared with women who did not undergo bilateral oophorectomy. The findings of the study are published in JAMA Network Open.
Preventive (prophylactic) bilateral oophorectomy is a preventive surgery to remove the ovaries for people with a high risk of ovarian and breast cancer. It carries benefits and risks that must be carefully balanced when considering this procedure. The use of estrogen therapy after oophorectomy with cognitive performance later in life remains controversial.
The objective of the study was to investigate whether women who underwent premenopausal bilateral oophorectomy were at increased risk of MCI and experienced decreased global or domain-specific cognitive performance.
The study was a case-control and cross-sectional study by combining data from the Mayo Clinic Study of Aging (MCSA) and the Rochester Epidemiology Project (REP) medical record–linkage system. The studies were conducted among a population-based sample in Olmsted County, Minnesota, consisting of 2732 women aged 50 to 89 years who participated in the MCSA study from 2004 to 2019 and underwent a clinical evaluation and comprehensive cognitive testing. Data were analyzed from January to May 2021.
The results of the study were
• Bilateral oophorectomy before menopause and before age 46 years was associated with clinically diagnosed MCI compared with no bilateral oophorectomy.
• The presence of an association with MCI varied by surgical indication, with an association among 259 women with bilateral oophorectomy before menopause and before age 50 years for the indication of benign ovarian condition (aOR, 2.430) but not for cancer or no ovarian condition.
• The presence of an association did not vary by estrogen therapy after bilateral oophorectomy, with associations among women aged less than 46 years with estrogen therapy (aOR, 2.56) and without estrogen therapy (aOR, 2.05).
• Premenopausal bilateral oophorectomy was performed before age 46 years among 161 women and was associated with decreased global cognition z score (β, −0.17), attention and executive domain z score (β, −0.21), and Short Test of Mental Status score (β, −0.51) compared with no bilateral oophorectomy.
Dr. Rocca, and the team concluded that "This study found that women who underwent bilateral oophorectomy before menopause had increased odds of MCI and poorer performance on cognitive tests approximately 30 years later compared with women who did not undergo bilateral oophorectomy."
Reference: Rocca WA, Lohse CM, Smith CY, Fields JA, Machulda MM, Mielke MM. Association of Premenopausal Bilateral Oophorectomy With Cognitive Performance and Risk of Mild Cognitive Impairment. JAMA Netw Open. 2021;4(11):e2131448. doi:10.1001/jamanetworkopen.2021.31448
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.